•
Sep 30, 2019

Jazz Pharmaceuticals Q3 2019 Earnings Report

Total Revenue
$538M
Previous year: $469M
+14.6%
EPS
$4.1
Previous year: $3.58
+14.5%
Gross Margin
94.1%
Gross Profit
$506M
Previous year: $443M
+14.3%
Cash and Equivalents
$795M
Previous year: $499M
+59.3%
Free Cash Flow
$326M
Total Assets
$5.53B
Previous year: $5.49B
+0.8%

Jazz Pharmaceuticals

Jazz Pharmaceuticals